Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Shares
  3. Lakeshore Hospital and Research Centre

Lakeshore Hospital and Research Centre Unlisted Share Price Today

ISIN INE01TI01010.

Lakeshore Hospital and Research Centre is a leading multi-specialty tertiary care hospital in Kerala. The hospital provides comprehensive healthcare services across key specialties including cardiology, neurology, oncology, nephrology, orthopedics, gastroenterology, and critical care. Its revenue mix is primarily derived from inpatient services, outpatient consultations, diagnostic services, surgical procedures, and allied healthcare offerings, with a strong focus on tertiary and quaternary c…

Lakeshore Hospital and Research Centre

Login to view price
Lakeshore Hospital and Research Centre

Lakeshore Hospital and Research Centre Unlisted Share Price Today

Price
Login to view
Loading chart data...
SectorHealthcare & Pharmaceuticals
ISININE01TI01010
Depository
Market Cap₹920 Cr
P/E Ratio17.33
ROE (%)12.9
Revenue₹452.73 Cr
Book Value45.56
Debt to EquityN/A
Face Value10
52W High₹115
52W Low₹54
Market Cap₹920 Cr
P/E Ratio17.33
ROE (%)12.9
Revenue₹452.73 Cr
Book Value45.56
Debt to EquityN/A
52W High/Low₹115 / ₹54
Face Value10
As of FY26

About the company & Industry

Lakeshore Hospital and Research Centre is a leading multi-specialty tertiary care hospital in Kerala. The hospital provides comprehensive healthcare services across key specialties including cardiology, neurology, oncology, nephrology, orthopedics, gastroenterology, and critical care. Its revenue mix is primarily derived from inpatient services, outpatient consultations, diagnostic services, surgical procedures, and allied healthcare offerings, with a strong focus on tertiary and quaternary care.

Lakeshore follows an asset-heavy, infrastructure-driven operating model, with significant investments in hospital buildings, advanced medical equipment, and clinical technology. The company emphasizes specialty-led care, high clinical standards, and service differentiation, rather than aggressive multi-city expansion. Its performance is closely linked to occupancy rates, case mix intensity, pricing power, insurance penetration, and medical tourism inflows, making operating leverage and asset utilisation key drivers of profitability.

Based in Kochi, Kerala, Lakeshore primarily caters to patients across Kerala and neighboring states, while also benefiting from inbound medical tourism demand.

Lakeshore Hospital and Research Centre is a leading multi-specialty tertiary care hospital in Kerala. The hospital provides comprehensive healthcare services across key specialties including cardiology, neurology, oncology, nephrology, orthopedics, gastroenterology, and critical care. Its revenue mix is primarily derived from inpatient services, outpatient consultations, diagnostic services, surgical procedures, and allied healthcare offerings, with a strong focus on tertiary and quaternary care.

Lakeshore follows an asset-heavy, infrastructure-driven operating model, with significant investments in hospital buildings, advanced medical equipment, and clinical technology. The company emphasizes specialty-led care, high clinical standards, and service differentiation, rather than aggressive multi-city expansion. Its performance is closely linked to occupancy rates, case mix intensity, pricing power, insurance penetration, and medical tourism inflows, making operating leverage and asset utilisation key drivers of profitability.

Based in Kochi, Kerala, Lakeshore primarily caters to patients across Kerala and neighboring states, while also benefiting from inbound medical tourism demand.

Financials

Revenue growth accelerated

Revenue from operations increased 11.09% YoY to ₹452.73 Cr in FY26, recovering from the slower growth seen in FY24–FY25.

Profitability improved

EBITDA increased from ₹79.10 Cr to ₹99.13 Cr, with EBITDA margin improving from 19.41% to 21.90% in FY26.

Strong PAT & EPS recovery

PAT grew 35.81% to ₹53.06 Cr, while diluted EPS increased from ₹3.91 to ₹5.31, marking a strong recovery after two consecutive years of decline.

Income Statement

Revenue(Figures in Cr.)

Revenue growth accelerated

Revenue from operations increased 11.09% YoY to ₹452.73 Cr in FY26, recovering from the slower growth seen in FY24–FY25.

Profitability improved

EBITDA increased from ₹79.10 Cr to ₹99.13 Cr, with EBITDA margin improving from 19.41% to 21.90% in FY26.

Strong PAT & EPS recovery

PAT grew 35.81% to ₹53.06 Cr, while diluted EPS increased from ₹3.91 to ₹5.31, marking a strong recovery after two consecutive years of decline.

Income Statement

Revenue(Figures in Cr.)

Competitive Position

Market Share

P/E Ratio

Financial Ratio Comparison (FY26)

Particulars
Lakeshore Hospital and Research Centre
Fortis Healthcare Ltd
Apollo Hospitals Enterprise Ltd
Revenue (₹ Cr)452.739127.8425228.50
Revenue Growth (%)11.0917.2815.76
EBITDA Margin (%)21.9023.3315.80
Net Profit Margin (%)11.7211.667.94
ROE (%)12.9011.0121.50
Debt to Equity0.000.280.57
Asset Turnover Ratio (x)0.830.621.18
Fixed Asset Turnover (x)1.301.823.23
ROCE (%)14.69--
ROA (%)9.77--
Operating Cash Flow to EBITDA Ratio (x)0.570.750.72

Market Share

P/E Ratio

Financial Ratio Comparison (FY26)

Particulars
Lakeshore Hospital and Research Centre
Fortis Healthcare Ltd
Apollo Hospitals Enterprise Ltd
Revenue (₹ Cr)452.739127.8425228.50
Revenue Growth (%)11.0917.2815.76
EBITDA Margin (%)21.9023.3315.80
Net Profit Margin (%)11.7211.667.94
ROE (%)12.9011.0121.50
Debt to Equity0.000.280.57
Asset Turnover Ratio (x)0.830.621.18
Fixed Asset Turnover (x)1.301.823.23
ROCE (%)14.69--
ROA (%)9.77--
Operating Cash Flow to EBITDA Ratio (x)0.570.750.72

Management

Shareholding PatternAs of FY26
Promoters
77.78%
Others
22.22%

Key Managerial Personnel

As of FY26
NameDesignation and Experience
Dr. Vayalil Parambath Shamsheer
Chairman
Mr. S.K. Abdulla
Managing Director
Mr. E. Gireeshkumar
Chief Financial Officer

Shareholding PatternAs of FY26
Promoters
77.78%
Others
22.22%

Key Managerial Personnel

As of FY26
NameDesignation and Experience
Dr. Vayalil Parambath Shamsheer
Chairman
Mr. S.K. Abdulla
Managing Director
Mr. E. Gireeshkumar
Chief Financial Officer
Available now

Register to view prices and access exclusive investments.

Minimum ticket ₹10,000 - Start small. No large capital lock-in.
Reserve Access
or
Continue with Google
Reserve Access

FAQs on Lakeshore Hospital and Research Centre Unlisted Shares

What is the unlisted share price today?

unlisted share price is updated regularly on Precize. Visit Precize to check price movements and market trends.

How do I buy unlisted shares?

Register on Precize.in, complete KYC, select , enter quantity, and pay via UPI or NEFT. Shares are transferred within 24 hours.

What is 's revenue and profitability?

Please read these important legal notices and disclosures

None of the information displayed on or downloadable from https://www.precize.in represents an offer to buy or sell or a solicitation of an offer to buy or sell any security, nor does it constitute an offer to provide investment advice or service. Registered representatives of precize do not (1) Advise any member on the merits or advisability of a particular investment or transaction, or (2) Assist in the determination of fair value of any security or investment, or (3) Provide legal, tax, or transactional advisory services.

Read more

© 2026 Precize All Rights Reserved.

DECLARATION OF RISKTERMS OF USEPRIVACY POLICY
reported revenue of ₹452.73 Cr in FYFY26. PAT was ₹53.06 Cr. See full financials on this page.

What is the minimum investment for unlisted shares?

Minimum investment for unlisted shares starts from ₹10000. Please log in to view the latest pricing and availability